Australia's HealthLinx Collaborates with Bruker Daltonics on Mass Spectrometry-Based Disease-Specific IVD Assays
HealthLinx Pty. Limited announced that it has entered into a collaboration with Bruker Daltonics Inc. The collaboration focuses on technology transfer and cooperation between the two firms to develop disease-specific assays for use in in-vitro diagnostic (IVD) research and clinical trials using Bruker Daltonics' CLINPROT(TM) platform technology for clinical proteomics.
The collaboration involves the on-going discovery of new biomarkers for predictive diagnostic applications using Bruker Daltonics' autoflex(TM) MALDI-TOF mass spectrometer in combination with proprietary CLINPROT magnetic bead sample preparation, and ClinProTools(TM) software for advanced visualization and bioinformatics. HealthLinx will apply this technology platform to develop and commercialize biomarker applications in women's health for both research and clinical diagnostics. It is envisaged that, following validation, Australian government Therapeutic Goods Administration (TGA) registration of the CLINPROT platform as a diagnostic pathology device will be sought. TGA registration has effect in both Australia and New Zealand, and is valuable in Singapore and Europe.
Most read news
Topics
Organizations
Other news from the department business & finance
These products might interest you
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Topic World Mass Spectrometry
Mass spectrometry enables us to detect and identify molecules and reveal their structure. Whether in chemistry, biochemistry or forensics - mass spectrometry opens up unexpected insights into the composition of our world. Immerse yourself in the fascinating world of mass spectrometry!
Topic World Mass Spectrometry
Mass spectrometry enables us to detect and identify molecules and reveal their structure. Whether in chemistry, biochemistry or forensics - mass spectrometry opens up unexpected insights into the composition of our world. Immerse yourself in the fascinating world of mass spectrometry!
Last viewed contents
Bone degradation process within metastatic breast cancer identified
Shimadzu acquires specialist for isotope labeled standards
CLC bio tests Next Generation Sequencing solution on African tuberculosis data
TTP LabTech Announce US Expansion to Meet Growing Customer Demand
Oncodesign announces EUR 10 million funding for oncology biomarker program IMAkinib
Let there be tissue-penetrating light - Scientists develop new nanoscale method to fight cancer
NUS partners FIND to discover novel biomarkers for Tuberculosis detection
New technology makes clinical research more precise
First-hand expertise at the biggest ever analytica Vietnam
Taking malaria breath markers to the world
New chemical imaging technique could help in the fight against atherosclerosis, suggests research